Quantum Biopharma (QNTM) Generating A Significant Buzz with Shares Up 230% YTD
Biopharmaceutical company Quantum BioPharma (QNTM) has seen its stock rocket up roughly 230% in the past month. The company ...
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...
Novartis buys Blackstone's Anthos for up to $3.1 billion
(Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...
BioWorld4d
Ellipses Pharma licenses monoclonal antibody targeting CNTN4 from Genome & Co.
Ellipses Pharma Ltd. has agreed to in-license global rights to GENA-104, a first-in-class immuno-oncology monoclonal antibody ...
Contract Pharma4d
Accord, Bio-Thera Partner on Simponi Biosimilar BAT2506
Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...